Section Arrow
SRPT.NASDAQ
- Sarepta Therapeutics
Quotes are at least 15-min delayed:2025/12/27 08:05 EST
Regular Hours
Last
 22.12
-0.2 (-0.90%)
Day High 
22.41 
Prev. Close
22.32 
1-M High
23 
Volume 
1.39M 
Bid
21.91
Ask
22
Day Low
21.86 
Open
22.36 
1-M Low
19.35 
Market Cap 
2.34B 
Currency 美元 
P/E 15.76 
%Yield -- 
10-SMA 21.52 
20-SMA 21.54 
50-SMA 20.78 
52-W High 129.84 
52-W Low 10.415 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.83/1.20
Enterprise Value
3.67B
Balance Sheet
Book Value Per Share
12.60
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
301.03M
Operating Revenue Per Share
10.55
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CANFCan-Fite BioPharma Ltd0.2139+0.0336+18.64%-- 
ASBPAspire Biopharma Holdings Inc.0.108+0.011+11.34%-- 
RXRXRecursion Pharmaceuticals4.25-0.15-3.41%-- 
APVOAptevo Therapeutics Inc0.6071-0.323-34.73%0PE
BHVNBiohaven Ltd11.15+0.34+3.15%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.